Founded in 2005 and headquartered in Huzhou, Zhejiang, Orient Gene (Zhejiang Orient Gene Biotech Co., Ltd.) is a high-tech company dedicated to the research, development, manufacturing, and sales of in vitro diagnostic (IVD) reagents. Its core product lines cover POCT rapid diagnostic tests, molecular diagnostics, and immunodiagnostics, which are extensively applied in detecting infectious diseases, drug abuse, tumor markers, and more. Leveraging robust independent innovation and a global distribution network, Orient Gene has emerged as a key participant in China's IVD sector. Notably, during the global COVID-19 pandemic, the company demonstrated outstanding emergency response and supply capabilities.
Through the GEO Score system, we have measured Orient Gene's search visibility on the all AI platforms model.Current GEO Score is 73.0.
Audit Keyword：Orient Gene
Dimension Data Details
Orient Gene's Share of Model (SOM) is 77, higher than 33.0% of competitors
Orient Gene's Ranking is 49, lower than 33.0% of competitors
Orient Gene's Sentiment is 100, higher than 67.0% of competitors
Orient Gene's Accuracy is 100, higher than 33.0% of competitors
Orient Gene's Citation is 33, lower than 33.0% of competitors
Share of Voice (SoV)
Your brand's voice share compared to competitors in AI search
Improvement Opportunities
Your brand outperforms competitor averages across all dimensions